October 26, 2022 Press release - Regulatory Invitation to Targovax’s third quarter 2022 presentation, Thursday 3 November
August 18, 2022 Press release - Regulatory Targovax ASA: Second quarter and first half year 2022 results
May 11, 2022 Press release - Regulatory Targovax announces clinical collaboration with Agenus for upcoming ONCOS-102 phase 2 melanoma trial
February 28, 2022 Press release - Regulatory Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer
February 9, 2022 Press release - Regulatory Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February
February 1, 2022 Press release - Regulatory Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration
January 12, 2022 Press release - Regulatory Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway